Feasibility and Acceptability of Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Utah
- Enrollment
- 39
- Locations
- 1
- Primary Endpoint
- Proportion of Participants Referred That Were Consented and Enrolled
Study Overview
Brief Summary
The long-term goal of this study is to determine the efficacy of time restricted eating (TRE) for improving metabolic health and preventing endometrial cancer. The primary objective of the protocol is to conduct a 14-week two-arm randomized crossover trial of a dietary intervention to evaluate the feasibility, fidelity and preliminary acceptability of a TRE intervention among Native Hawaiian/Pacific Islander women at risk for developing endometrial cancer, and to provide proof of principle that TRE can improve metabolic health in this population.
Detailed Description
Enrollment: The study includes two phases. Phase 1 includes focus groups among 30 Native Hawaiian/Pacific Islander women at risk of endometrial cancer. Focus groups will determine sociocultural influences on (i) dietary behavior including meal timing; (ii) dietary preferences; (iii) proposed meal plans and intervention design; (iv) perceptions of weight loss and body image. In the second study phase, the study team will recruit 10 Pacific Islander women to participate in a 14-week randomized dietary crossover study. Each woman will participate in both intervention arms and act as her own control.
Focus Group: To accomplish all aspects of Aim 1 of this study, the study team will recruit 30 Pacific Islander women at risk for endometrial cancer to conduct virtual focus groups. These focus groups will take place via private videoconference, like Zoom, and a language translator will be provided, as necessary. The focus groups will be attended by a Native Hawaiian/Pacific Islander Community Expert. Questions will be designed to understand sociocultural influences on dietary behavior (questions on social eating, meal timing, and dietary preferences, soliciting feedback on study intervention delivery design, and perceptions of weight loss and body image). An icebreaker will be conducted prior to formal questioning. Sessions will be audio-recorded on the videoconference and an additional device, transcribed verbatim, and checked for accuracy. Two additional team members will be present as note takers. Our Community Expert will be present to help facilitate the session. Questions will be provided at the beginning of the session to ensure cultural sensitivity.
Dietary Intervention: The dietary intervention includes 5 study visits, and features a baseline visit, 2-week run-in period, 4-week control diet schedule, 4-week washout period, and a 4-week, 8 to 10-hour Time Restricted Eating (TRE) protocol (8 to 10-hour feeding and 14 to 16-hour fasting periods). A follow-up questionnaire will be mailed 6-months post- intervention. For the control schedule, women will receive frozen lunch and dinner meals and a standardized breakfast and snacks menu. All meals and the breakfast/snack menu will be designed to be culturally competent with feedback from the focus groups, and meal plans will be individualized to meet weight maintenance energy requirements. For the TRE schedule, women will receive prepared frozen lunch and dinner meals as per the control schedule, but will be asked to consume daily meals, snacks, and calorie-containing beverages within an 8 to 10-hour period that fits their schedule. They will be asked to maintain their regular sleep and physical activity schedule. The fasting period will ramp up during the first week (Days 1-3, 12-14 h per day, Days 4-6, 14-16 h per day, Days 7+, 16 h per day). Women will be asked to schedule the eating period at the same time each day. All meals (control and TRE) will be provided by the Metabolic Kitchen located at the University of Utah.
Visit 1: During the baseline visit, a coordinator will obtain consent from the participant, and they will be asked to compete questionnaires asking about clinical and demographic factors, chronotype, and physical activity, and various anthropometric measurements will be taken. Following the baseline visit, participants will undergo a 2-week run-in period. During this time, the goal is to record women's usual times of eating episodes and appetite while following their habitual diet.
Visit 2: Women will provide fasting blood and stool samples, and anthropometric measurements will be taken. Following visit 2, participants will undergo the control or TRE schedule for 4 weeks.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Native Hawaiian/Pacific Islander females aged 18 years or older
- •Overweight or obese (BMI>25kg/m2) OR have a history of non-insulin dependent diabetes OR have a history of complex atypical endometrial hyperplasia
- •Have a working cell phone that can download an App
- •Able to use cell phone during day (e.g. at work)
- •Not a night shift worker
- •Applicable Only to Aims 2 & 3:
- •Able to attend study visits at the Huntsman Cancer Institute Center for HOPE
Exclusion Criteria
- •Unable to provide informed consent
- •Applicable Only to Aims 2 & 3:
- •Necessity of a special diet that precludes adjustment of meal timing and/or macronutrient content
- •Have a history of insulin dependent diabetes
- •Have a history of hysterectomy
Arms & Interventions
Time Restricted Eating (TRE) Schedule, Then Control
In this arm of the 14-week randomized dietary crossover study, participants will undergo a 2-week run-in period, followed by an 8-hour TRE protocol (comprising 8 hours of feeding and 16 hours of fasting periods), a 4-week washout period, and a 4-week control diet schedule.
Intervention: Time Restricted Eating (TRE) Schedule (Behavioral)
Time Restricted Eating (TRE) Schedule, Then Control
In this arm of the 14-week randomized dietary crossover study, participants will undergo a 2-week run-in period, followed by an 8-hour TRE protocol (comprising 8 hours of feeding and 16 hours of fasting periods), a 4-week washout period, and a 4-week control diet schedule.
Intervention: Control Schedule (Behavioral)
Control Schedule, Then TRE
In this arm of the 14-week randomized dietary crossover study, participants will undergo a 2-week run-in period, followed by 4-week control diet schedule, a 4-week washout period, and an 8-hour TRE protocol (comprising 8 hours of feeding and 16 hours of fasting periods)
Intervention: Time Restricted Eating (TRE) Schedule (Behavioral)
Control Schedule, Then TRE
In this arm of the 14-week randomized dietary crossover study, participants will undergo a 2-week run-in period, followed by 4-week control diet schedule, a 4-week washout period, and an 8-hour TRE protocol (comprising 8 hours of feeding and 16 hours of fasting periods)
Intervention: Control Schedule (Behavioral)
Outcomes
Primary Outcomes
Proportion of Participants Referred That Were Consented and Enrolled
Time Frame: up to 1 day after screening
The feasibility of the Time-Restricted Eating (TRE) intervention will be measured by calculating the proportion (%) of women who were consented and enrolled in the study out of all the participants who screened for the trial.
Attrition
Time Frame: From the baseline of the randomized portion of the study to Visit 5, up to 19 weeks
To assess the feasibility of the TRE intervention. This outcome measure will report the number of participants who withdrew throughout the course of the interventional component of the study.
Protocol Items Completed
Time Frame: From the baseline of the randomized portion of the study to Visit 5, up to 19 weeks
This outcome measure will report the count of participants who completed each study assessment per protocol. Participants who were randomized and withdrew from the study are included as missed assessments. After the TRE Schedule (Visit 3 or 5), waist circumference, weight, blood pressure, blood, and stool were collected. After the Control Schedule (Visit 3 or 5), waist circumference, weight, blood pressure, blood, and stool were collected. This outcome measure will report the count of participants who completed each assessment
Percentage of TRE-Adherent Days
Time Frame: From the baseline of the randomized portion of the study to Visit 3 and Visit 5, up to 19 weeks
This outcome measure will report the mean percentage of TRE-adherent days. TRE adherence is achieved when participants fast for 14-18 hours per day during the TRE phase, as measured by a mealtime log using the MyCircadianClock phone app.
Meals Delivered On Schedule
Time Frame: From the baseline of the randomized portion of the study to Visit 5, up to 19 weeks
Count of participants whose pre-made control diet meals were delivered on schedule. Participants were provided with pre-made, frozen lunch and dinner meals 7 days a week during both 4-week diet phases.
Study Visit Completion
Time Frame: From the baseline of the randomized portion of the study to Visit 5, up to 19 weeks
To assess feasibility of the study, the percentage of in-person study visits completed out of 5 study visits for each participant was calculated. This outcome measure will report the mean percentage of completed study visits. This outcome measure was assessed throughout the course of the study during both the TRE and Control Schedules; it is not possible to regroup participants to report Arms/Groups "per intervention".
Secondary Outcomes
- Blood Pressure Measured With Electronic Blood Pressure Monitor(From the baseline of the randomized portion of the study to Visit 3 and Visit 5, up to 19 weeks)
- Waist Circumference(From the baseline of the randomized portion of the study to Visit 3 and Visit 5, up to 19 weeks)
- Body Mass Index (BMI) Assessed Via Stadiometer and Calibrated Scales(From the baseline of the randomized portion of the study to Visit 3 and Visit 5, up to 19 weeks)
- Fasting Blood Glucose Level(From the baseline of the randomized portion of the study to Visit 3 and Visit 5, up to 19 weeks)
- Fasting Blood C-peptide Level(From the baseline of the randomized portion of the study to Visit 3 and Visit 5, up to 19 weeks)
- Fasting Blood Triglyceride Level(From the baseline of the randomized portion of the study to Visit 3 and Visit 5, up to 19 weeks)
- Fasting Blood High-density Lipoprotein(HDL)-Cholesterol Level(From the baseline of the randomized portion of the study to Visit 3 and Visit 5, up to 19 weeks)
- Fasting Blood High Sensitivity C-reactive Protein(From the baseline of the randomized portion of the study to Visit 3 and Visit 5, up to 19 weeks)
Investigators
Mary Playdon
Assistant Professor, Investigator
University of Utah
